Added to YB: 2025-08-05
Pitch date: 2025-08-01
NAN.AX [bearish]
Nanosonics Limited
-1.8%
current return
Author Info
No bio for this author
Company Info
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies.
Market Cap
AUD 1.2B
Pitch Price
AUD 3.89
Price Target
N/A
Dividend
N/A
EV/EBITDA
51.30
P/E
72.57
EV/Sales
5.65
Sector
Health Care Equipment and Supplies
Category
turnaround
Nanosonics Limited - $NAN.AX
NAN.AX short: Single-product medtech at 56x EV/EBITDA with saturated TAM (~90%) & new competitor entering. Core Trophon facing negative sales growth as emergent 60k unit TAM is overstated (real TAM ~35k). CORIS likely to fail commercialization due to infrastructure needs & strong incumbents. Expect 2-year negative sales/EPS vs market's +20% growth expectation.
Read full article (5 min)